GLP-1 Drugs Linked to GI Effects, Uncertain Signals Umbrella review evaluates over 1,700 trials to assess noncardiometabolic outcomes beyond weight and glycemic effects. By Kathryn Wighton April 16, 2026 3 min Conexiant Share Summary Takeaways Listen Insight Report Clinical Scorecard Quiz Poll Top Thought Leaders